Colorectal cancer (CRC) is the most frequently occurring malignancy in the world. However,
the mortality from CRC can be reduced through early diagnostics, selection of the most …

Worldwide, colorectal cancer (CRC) is a deadly disease whose death rate ranks second
among cancers though its incidence ranks third. Early CRC detection is key and is …

Screening methods for the most frequent diagnosed malignant tumor, colorectal cancer
(CRC), have limitations. Circulating cell-free DNA (cfDNA) analysis came into focus as a …

Liquid biopsy has emerged as a promising noninvasive approach for colorectal cancer
(CRC) management. This review focuses on technologies detecting circulating nucleic …

Colorectal cancer (CRC) is the third most prevalent cancer in the world. Globally, it has been
estimated that about 1.4 million new cases of colorectal cancer are diagnosed every year …

Colorectal cancer (CRC) is a disease without evident clinical symptoms in early stages,
leading to late diagnosis and disease management. Current diagnostic and prognostic tools …

In recent years, the need to identify molecular markers characterized by high sensitivity and
specificity in detecting and monitoring early and colorectal cancer lesions has increased. Up …

Colorectal cancer (CRC) is still a leading cause of cancer death worldwide. Less than half of
cases are diagnosed when the cancer is locally advanced. CRC is a heterogenous disease …

Circulating tumor DNA (ctDNA) is the small genomic fragment released by tumor cells into
the circulating system, which carries the gene variation features, such as mutation, insertion …

Circulating tumour DNAs and non-coding RNAs present in body fluids have been under
investigation as tools for cancer diagnosis, disease monitoring, and prognosis for many …